Equities

ZYUS Life Sciences Corp

ZYUS:CVE

ZYUS Life Sciences Corp

Actions
  • Price (CAD)0.92
  • Today's Change0.00 / 0.00%
  • Shares traded10.98k
  • 1 Year change-8.91%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 14:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

SmartText is unavailable
Gross margin46.50%
Net profit margin-8,604.67%
Operating margin-9,752.57%
Return on assets-63.34%
Return on equity-110.77%
Return on investment-88.37%
More ▼

Cash flow in CADView more

SmartText is unavailable
Cash flow per share-0.4803
Price/Cash flow per share--
Book value per share0.2192
Tangible book value per share-0.0432
More ▼

Balance sheet in CADView more

SmartText is unavailable
Current ratio0.2952
Quick ratio0.1593
Total debt/total equity0.6542
Total debt/total capital0.3955
More ▼

Growth rates in CAD

Year on year, growth in earnings per share excluding extraordinary items dropped -18.45%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-3.09
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.